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Advanced cancer is associated with emotional distress, especially depression and feelings of sadness. To date, it is unclear which is the
most effective way to address these problems. This review focuses on the effects of psychosocial interventions on the quality of life
(QoL) of patients with advanced cancer. It was hypothesised that patients will benefit from psychosocial interventions by improving
QoL, especially in the domain of emotional functioning. The review was conducted using systematic review methodology involving a
systematic search of the literature published between 1990 and 2002, quality assessment of included studies, systematic data
extraction and narrative data synthesis. In all, 10 randomised controlled studies involving 13 trials were included. Overall interventions
and outcome measures across studies were heterogeneous. Outcome measures, pertaining to the QoL dimension of emotional
functioning, were most frequently measured. A total of 12 trials evaluating behaviour therapy found positive effects on one or more
indicators of QoL, for example, depression. The results of the review support recommendation of behaviour therapy in the care of
patients with advanced cancer.
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In 1998, approximately 60000 new cancer patients were diagnosed
in the Netherlands (Visser et al, 2002). In that same year, 37000
patients died of this disease (Visser et al, 2002). About half of all
patients cannot be cured and receive treatment with a palliative
intent.
Clearly, the emotional impact of a cancer diagnosis is
devastating and characterised by shock, disbelief, anger, anxiety,
depression and difficulty in performing activities of daily living. A
similar response occurs at each transitional point of the disease,
that is, beginning treatment, recurrence, treatment failure and
disease progression (Pasacreta and Pickett, 1998). Although it is
obvious that many patients with cancer experience emotional
distress, van’t Spijker et al (1997) found that percentages for
depression varied from 0 to 46%, for anxiety from 0.9 to 49% and
for general psychological distress from 5 to 50%. These data do not
refer to patients in a specific stage of cancer, which may account
for the wide variation in prevalence rates. Less variation in
prevalence rates of emotional distress is found in patients with
advanced disease. In this population, emotional distress and
depression, in particular, appear to be a common problem (Zabora
et al, 1997; Massie and Popkin, 1998). Hotopf et al (2002)
estimated that the prevalence of depression ranged from 15% for
major depression to at least 30% for all depressive disorders
(including minor depression).
Moreover, several studies (Slevin et al, 1996; Sanson-Fisher et al,
2000; Soothill et al, 2001) report that patients in an advanced stage
of the disease have high levels of psychosocial needs that are not
properly met. Professional caregivers appear to be selective in their
receptiveness of patients’ needs, focus on physical problems and to
a much lesser extent on emotional problems and psychosocial
needs. This implies that psychological problems and emotional
needs are not adequately assessed (Heaven and Maguire, 1997;
Sanson-Fisher et al, 2000; Fallowfield et al, 2001) and consequently
addressed (Wilkinson, 1991; Dennison, 1995; Ford et al, 1996;
Maguire et al, 1996; Heaven and Maguire, 1997; Suchman et al,
1997; Maguire, 1999; Osse et al, 2000; Andersen and Adamsen,
2001; Uitterhoeve et al, 2003).
In the last decade, several systematic reviews (Trijsburg et al,
1992; Devine and Westlake, 1995; Meyer and Mark, 1995; Sheard
and Maguire, 1999; Barsevick et al, 2002; Newell et al, 2002) were
published about the effectiveness of psychosocial interventions for
a general population of patients with cancer. Each review had
somewhat different objectives, for example, outcomes of interest
between reviews ranged from all possible psychosocial outcomes to
survival and immune outcomes. Similarly, each review employed
different inclusion criteria and controlled for study quality in
different ways. Despite these differences, overall it appears that
psychosocial interventions to some extent may help patients with
cancer. Especially, patients identified as either suffering from or
Received 17 November 2003; revised 9 June 2004; accepted 30 June
2004; published online 17 August 2004
*Correspondence: RJ Uitterhoeve; E-mail: r.uitterhoeve@cis.umcn.nl
British Journal of Cancer (2004) 91, 1050–1062
& 2004 Cancer Research UK All rights reserved 0007– 0920/04 $30.00
www.bjcancer.com
C
l
i
n
i
c
a
lbeing at high risk for psychological distress seem to benefit
(Sheard and Maguire, 1999). None of the mentioned reviews
(Trijsburg et al, 1992; Devine and Westlake, 1995; Meyer and
Mark, 1995; Sheard and Maguire, 1999; Newell et al, 2002;
Barsevick et al, 2002), however, explicitly focused on the effects
of psychosocial interventions in patients with cancer in an
advanced stage of the disease.
Hence, a systematic review of the literature on the effectiveness
of psychosocial interventions in patients with advanced cancer is
conducted. It is hypothesised that patients with advanced cancer
will benefit from psychosocial interventions by improving quality
of life (QoL), especially in the domain of emotional functioning.
The aim of this systematic review was to identify and examine all
known controlled studies published between 1990 and 2002
pertaining to the efficacy of psychosocial interventions on the
QoL of adult cancer patients in an advanced stage of the disease.
MATERIALS AND METHODS
Search strategy
First, computerised databases of Medline (1989–2002), PsycInfo
(1988–2002) and Cinahl (1982–2002) were searched using the
following procedure. Subject-specific keywords used to describe
patients and interventions relevant to this review were selected by
using the thesaurus function of the databases. The selected subject-
specific keywords for patients and psychosocial interventions were
separately combined (using Boolean operator ‘OR’) with relevant
free text words. The two searches were then combined (using
Boolean operator ‘AND’) to limit the search to studies with cancer
patients in an advanced stage of the disease, which mention
psychosocial or any of the approximate synonyms for psychosocial
interventions. Next, the above combined search was then,
respectively, combined (using Boolean operator ‘AND’) with a
database specific methodological filter adapted from Robinson and
Dickersin (2002) limiting the search to controlled studies. The
search was then limited to papers published between 1990 and
2002 (Table 1). Second, abstracts of references of all relevant
papers were retrieved and checked to identify additional studies.
Third, to identify additional relevant studies the Science Citation
Index was used to search for studies that have cited located,
relevant papers. Fourth, leaders in the field were contacted to
locate relevant but currently unpublished studies or suggest others
who possibly know of unpublished work.
Inclusion criteria
Retrieved studies were independently assessed for inclusion by two
reviewers (RU and KP) and included if all of the inclusion criteria
were met. Inclusion and exclusion criteria are summarised in
Table 2. Disagreement over inclusion between the reviewers was
resolved through discussion. When no consensus could be
achieved, a third researcher (TvA) decided.
Similar to previous reviews (Meyer and Mark, 1995; Barsevick
et al, 2002) psychosocial interventions are defined to include
Table 1 Search strategy
Medline (1990–2002) Cinahl (1990–2002) PsycInfo (1990–2002)
((((‘Neoplasms-’/all subheadings in MIME,MJME) or
(cancer* in ab) or (tumor* in ab) or (tumour* in
ab) or (malign* in ab) or (oncolog* in ab)) and
((‘Palliative-Care’/all subheadings in MIME,MJME) or
(‘Terminal-Care’/all subheadings in MIME,MJME) or
(‘Hospice-Care’/all subheadings in MIME,MJME) or
(‘Terminally-Ill’/all subheadings in MIME,MJME) or
(incurable in ab) or (incurable in ti) or (advanced in
ab) or (advanced in ti) or (palliat* in ab) or (palliat*
in ti) or (terminal* in ab) or (terminal* in ti))) and
((explode ‘Psychotherapy-’/all subheadings in
MIME,MJME) or (‘Patient-Education’/all subheadings
in MIME,MJME) or (‘Cognitive-Therapy’/all
subheadings in MIME,MJME) or (explode ‘Behavior-
Therapy’/all subheadings in MIME,MJME) or
(explode ‘Adaptation-Psychological’/all subheadings
in MIME,MJME) or (‘Counseling-’/all subheadings in
MIME,MJME) or (‘Social-Support’/all subheadings in
MIME,MJME) or (psychosocial in ab) or
(psychosocial in ti))) and (((Randomized-
Controlled-Trial in pt) or (Controlled-Clinical-Trial
in pt) or (randomized controlled trials in
MIME,MJME) or (random allocation in MIME,MJME)
or (double-blind method in MIME,MJME) or (single-
blind method in MIME,MJME) or (Clinical-Trial in
pt) or (clinical trials in MIME,MJME) or (‘clinical trial’)
or ((singl* or doubl* or trebl* or tripl*) and (mask*
or blind*)) or (‘latin square’) or (placebos in
MIME,MJME) or placebo* or random* or (research
design in MIME,MJME) or (comparative study in
MIME,MJME) or (evaluation studies in MIME,MJME)
or (follow-up studies in MIME,MJME) or
(prospective studies in MIME,MJME) or (cross-over
studies in MIME,MJME) or control* or prospective*
or volunteer*) not ((animal in MIME,MJME) not
(human in MIME,MJME)))
(((‘Neoplasms-’/all topical subheadings/all age
subheadings in DE) or (cancer in ab) or (tumor* in ab)
or (tumour* in ab) or (malign* in ab) or (oncolog* in
ab)) and ((explode ‘Terminal-Care’/all topical
subheadings/all age subheadings in DE) or (‘Terminally-
Ill-Patients’/all topical subheadings/all age subheadings in
DE) or (incurable in ab) or (incurable in ti) or
(advanced in ab) or (advanced in ti) or (palliat* in ab) or
(palliat* in ti) or (terminal* in ab) or (terminal* in ti))))
and (((explode ‘Psychotherapy-’/all topical subheadings/
all age subheadings in DE) or (explode ‘Behavior-
Therapy’/all topical subheadings/all age subheadings in
DE) or (‘Coping-’/all topical subheadings/all age
subheadings in DE) or (( ‘Caregiver-Support’/all topical
subheadings/all age subheadings in DE) or ( ‘Support-
Groups’/all topical subheadings/all age subheadings in
DE)) or (‘Social-Networks’/all topical subheadings/all
age subheadings in DE) or (explode ‘Counseling-’/all
topical subheadings/all age subheadings in DE) or
(‘Death-Education’/all topical subheadings/all age
subheadings in DE) or (‘Patient-Education’/all topical
subheadings/all age subheadings in DE) or (psychosocial
in ab) or (psychosocial in ti)) and ((Clinical-Trial in DT)
or (clinical-trials in DE) or (double-blind-studies in DE)
or (single-blind-studies in DE) or (triple-blind-studies in
DE) or ((singl* or doubl* or trebl* or tripl*) and
(mask* or blind*)) or (‘latin square’) or (placebo in DE)
or placebo* or random* or (study design in DE) or
(explode ‘quasi experimental studies’/all topical
subheadings/all age subheadings in DE) or (pretest
posttest control group design in DE) or (solomon four
group design in DE) or (crossover design in DE) or
(repeated measures in DE) or (pretest posttest design
in DE) or (experimental studies in DE) or control* or
prospective* or volunteer* or compar*)
((((‘Neoplasms-’ in DE) or (cancer in ab) or (tumor* in
ab) or (tumour* in ab) or (malign* in ab) or (oncolog*
in ab)) and ((‘Palliative-Care’ in DE) or (( ‘Terminal-
Cancer’ in DE) or ( ‘Terminally-Ill-Patients’ in DE)) or
(‘Hospice-’ in DE) or (incurable in ab) or (incurable in
ti) or (advanced in ab) or (advanced in ti) or (palliat* in
ab) or (palliat* in ti) or (terminal* in ab) or (terminal* in
ti))) and ((‘Coping-Behavior’ in DE) or (‘Support –
Groups’ in DE) or (‘Social-Support-Networks’ in DE) or
(explode ‘Psychotherapy –’ in DE) or (‘Cognitive-
Therapy’ in DE) or (‘Art-Therapy’ in DE) or
(‘Counseling-’ in DE) or (‘Self-Management’ in DE) or
(‘Client-Education’ in DE) or (psychosocial in ab) or
(psychosocial in ti))) and ((experimental design in DE)
or (Clinical-Trial in pt) or (clinical trial) or ((singl* or
doubl* or trebl* or tripl*) and (mask* or blind*)) or
(‘latin square’) or (placebo in DE) or placebo* or
random* or (follow-up studies in DE) or (prospective
studies in DE) or (repeated-measures in DE) or
(Treatment-Outcome-Study in pt) or (treatment
effectiveness evaluation in DE) or control* or
prospective* or volunteer* or compar*)
Hits 328 Hits 179 Hits 77
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provision of information, social support or a combination of
interventions. Quality of life was operationalised in global
measures of QoL and measures concerning patient’s emotional
functioning (e.g. coping, mood state such as anxiety and
depression or other type of emotional distress), social functioning,
physical functioning (e.g. symptom distress, activity level,
performance status, activities of daily living) and existential or
spiritual concerns.
Methodological quality
The adagium ‘garbage in–garbage out’ reveals that study quality is
clearly relevant when conducting a systematic review. There is,
however, limited empirical evidence of a relation between specific
methodological quality criteria and bias, except for adequate
concealment of treatment allocation and double blinding (van
Tulder et al, 1997). Especially, the use of summary scores to
identify studies of low or high quality is controversial (Moher et al,
1995; Ju ¨ni et al, 1999). Consequently, it is generally recommended
to assess study quality against individual relevant methodological
criteria, depending on the context in which studies are conducted,
however, always including criteria concerning the internal validity
of studies (Ju ¨ni et al, 1999, 2001). In this review the methodological
quality of included studies was independently assessed by two
reviewers (RU and ML) against nine criteria of internal validity
(van Tulder et al, 1997). Each criterion was scored as yes, no or as
providing insufficient information for adequate assessment. To
ensure standardised scoring, a pilot-tested predesigned table was
used. Disagreement among the reviewers was resolved by
discussion.
Data extraction
RU and ML independently extracted data. Predesigned tables were
used to ensure that data extraction was standardised. Extracted
information included: the sample (inclusion/exclusion criteria,
type of cancer and disease stage), the setting (inpatient, outpatient,
hospice and home-care setting), type of psychosocial intervention
(counselling/psychotherapy, behaviour therapy, education and
provision of information, social support and other psychosocial
approaches), format of psychosocial intervention (group vs
individual, structured vs unstructured, therapist, that is, psy-
chotherapist or psychologist vs nurse delivered), time frame of
psychosocial intervention (frequency, duration and follow-up),
description of comparison group, nature of the outcomes
measured (overall QoL, dimensions of QoL and other measured
outcomes) and the study design. Disagreement among the
reviewers was resolved by discussion.
Only measurements immediately post-treatment were included.
When a study compared more than one intervention arm with the
control arm, each intervention arm was labelled as a separate trial.
It was envisioned that studies would be too heterogeneous to be
combined using a formal meta-analysis. Therefore, a narrative
synthesis was performed. The results are summarised according to
type of intervention used and outcome measures assessed. The
magnitudes of effects on each outcome measure are reported as the
magnitudes of differences in change scores between groups,
relative to the scale used.
RESULTS
A total of 10 studies involving 13 trials were identified for inclusion
in the review. The search of Medline, PsycInfo and Cinahl
databases provided a total of 584 citations (Table 1). After
adjusting for duplicates 509 remained. Of these, 479 studies were
discarded because after reviewing the abstracts it appeared that
these papers clearly did not meet the criteria. Three additional
studies (Levy et al, 1990; Lee et al, 1997; Esper et al, 1999) were
discarded because full text of the study was not available or the
paper could not be feasibly translated into English. The full text of
the remaining 27 citations was examined in more detail. It
appeared that 22 studies did not meet the inclusion criteria as
described (Table 3). Five studies (Connor, 1992; Corner et al, 1996;
Scholten et al, 2001; Giese-Davis et al, 2002; Sloman, 2002) met the
inclusion criteria and were included in the systematic review. An
additional five studies (Arathuzik, 1994; Bredin et al, 1999;
Edelman et al, 1999; Classen et al, 2001; Goodwin et al, 2001)
that met the criteria for inclusion were identified by checking the
references of located, relevant papers and searching for studies
that have cited these papers. No unpublished relevant studies were
obtained.
Table 2 Inclusion and exclusion criteria
Inclusion criteria:
A controlled study with a psychosocial intervention in at least one arm of the study
A study population of adult patients (X18 years of age) with cancer in an
advanced stage of the disease (stage IV)
One (or more) dimension(s) of QoL should be at least one of the presented
outcome measures
Exclusion criteria:
Studies concerning interventions that were not strictly psychosocial such as
complementary therapies
Studies that used a comparison group other than usual care or attentional control
group
Studies of which less than 50% of patients had cancer in an advanced stage of the
disease
Table 3 Excluded studies (n¼22)
Reason for exclusion Studies
Less than 50% of patients with advanced
cancer
Decker et al (1992), Syrjala et al (1995), Johansson et al (1999), Oyama et al (2000), Carlson et al (2001), Lordick et al
(2002) and Walker et al (1999a,b)
No controlled study design Greer et al, 1991; Eysenck and Grossarth-Maticek, 1991; Bottomley, 1996; de Vries et al, 1997; Greer and Moorey, 1997;
Cwikel and Behar, 1999; Gallagher and Steele, 2001)
Intervention not strictly psychosocial Siegel et al (1992), Wilkinson et al (1999) and Ringdal et al (2001)
No QoL-related outcome measure Sloman et al (1994) and Bruera et al (1999)
Comparison group other than usual care Mantovani et al (1996) and Liossi and White (2001)
QoL¼quality of life.
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Characteristics of the included trials are shown in Table 4. All 13
included trials used a randomisation procedure to allocate the
psychosocial intervention. Included trials were predominantly
conducted in Europe (n¼3 trials) and the United States of
America and Canada (n¼6).
Sample characteristics The mean sample size of the intervention
and control group was 39 (range 8–158 patients) and 31 patients
(range 8–77 patients), respectively. The average age of patients
ranged from 50 to 67 years. In eight trials, the majority of patients
were female. Seven trials included only female patients and
concerned patients with breast cancer. Six trials recruited patients
with cancer at any site. Three trials (Connor, 1992; Corner et al,
1996; Bredin et al, 1999) limited the inclusion to patients who were
clearly in far advanced stages of the disease. The mean percentage
of patients with advanced disease (stage IV) was 89% (range 63–
100%).
Setting The majority of the trials were conducted in an outpatient
(n¼7 trials) or home-care setting (n¼3). Only one trial was
conducted in an in-patient setting. Two trials were conducted in a
combination of in- and outpatient settings.
Type of intervention The content of the experimental psychoso-
cial interventions was quite different. However, behaviour therapy
was used in 12 trials, including one or more of the following:
relaxation exercises, guided imagery, visualisation or cognitive
approaches focusing on changing specific thoughts or beliefs and
learning specific coping skills. In six (Arathuzik, 1994; Scholten
et al, 2001; Sloman, 2002) of these 12 trials, behaviour therapy was
used as a single intervention. A combined intervention of
behaviour therapy and group support was used in four trials
(Edelman et al, 1999; Goodwin et al, 2001; Classen et al,
2001; Giese-Davis et al, 2002). The group-support intervention
in these trials involved the creation of a supportive environment
in which patients were encouraged to express their emotions
about cancer and its broad-ranging effects on their lives.
Patients were also encouraged to interact with and support
each other. Practical or structural aspects of social support
were not covered in these studies. Two trials (Corner et al, 1996;
Bredin et al, 1999) combined behaviour therapy with
counselling and involved training in breathing control techniques,
relaxation and distraction exercises. In addition, the meaning of
breathlessness, their disease and patients’ feelings about the future
were explored.Counselling was used as a single intervention in one
trial. In this trial (Connor, 1992), terminally ill ambulatory patients
were interviewed to create an opportunity for the patient to
explore and to gain insight into his own coping processes. The
interview was paced so that those who gave guarded responses
were not required to elaborate. Subjects who were less guarded
were encouraged to talk more about their feelings, perceptions and
memories.
Format of the intervention Four trials (Edelman et al, 1999;
Classen et al, 2001; Goodwin et al, 2001; Giese-Davis et al, 2002)
delivered the intervention in a group format. Nurses or both
nurses and therapists, that is, psychotherapists or psychologists,
delivered the intervention in a majority of trials (n¼8). In eight
trials interventions were tailor-made to the needs and preferences
of included patients, whereas the intervention in five trials was
standardised. A total of 10 trials involved a multisession
intervention, of which four trials (Edelman et al, 1999; Classen
et al, 2001; Goodwin et al, 2001; Giese-Davis et al, 2002) delivered
the intervention during a period of 8 weeks or longer (up to 1
year).
Outcome measures Outcome measures to investigate the effects
of the interventions were all questionnaire based except in one trial
(Scholten et al, 2001), which additionally used semistructured
interviews.
Outcome measures were strongly heterogeneous, especially
coping measures, measures of physical functioning and global
measures of QoL.
Five different measures of emotional distress were used across
11 trials. The Profile of Mood States (McNair et al, 1992) and the
Hospital Anxiety and Depression Scale (Zigmond and Snaith,
1983) were the most frequently used (n¼5 trials) measures. The
Rotterdam Symptom Checklist, psychological symptom distress
subscale (De Haes et al, 1996), was used in the trial of Bredin et al
(1999). In one trial (Edelman et al, 1999), the Coopersmith Self-
Esteem Inventory (Myhill and Lorr, 1978) was used. In another
trial (Connor, 1992), death anxiety was measured using a scale of
the same name (McMordie, 1979).
Seven different measures of coping were used across six trials.
The Courtauld Emotional Control Scale (Watson and Greer, 1983),
Weinburger Adjustment Inventory (Weinberger, 1997) and
Stanford Emotional Self-Efficay Scale – Cancer (Giese-Davis et al,
2002) were used in a trial (Giese-Davis et al, 2002) to, respectively,
measure the extent to which patients report they suppress negative
affect, restrain from aggressive behaviour and are emotional self-
efficacious. Patients’ perceived ability to decrease or control pain
(Rosenstiel and Keefe, 1983) was measured in two trials
(Arathuzik, 1994). In one trial (Connor, 1992), the use of denial
was measured by the Defense Mechanism Inventory (Gleser and
Sacks, 1973). In another trial (Classen et al, 2001), the Impact of
Event Scale (IES) (Sundin and Horowitz, 2002) was used to
measure symptoms of intrusion and avoidance. Semistructured
interviews to measure coping skills were used once (Scholten et al,
2001).
Physical functioning was measured across five trials by six
different measures of physical functioning, varying from the
Rotterdam Symptom Checklist, physical symptom distress sub-
scale (De Haes et al, 1996) to a visual analogue scale measuring
distress due to breathlessness (Corner et al, 1996; Bredin et al,
1999).
Four different global measures of QoL, for example, the
Rotterdam Symptom Checklist subscale – overall evaluation of
QoL and the Functional Living Index – cancer scale, were used
across five trials.
Methodological quality of included trials
The methodological quality of the included trials is summarised in
Table 5. In five trials (Bredin et al, 1999; Edelman et al, 1999;
Classen et al, 2001; Goodwin et al, 2001; Giese-Davis et al, 2002),
treatment allocation was adequately concealed. This was either
carried out through central off-site randomisation, block rando-
misation or an adaptive randomisation-biased coin design. In eight
trials, insufficient information was available to assess if conceal-
ment of treatment allocation was adequately performed.
The number of trials that had similar groups at baseline with
regard to the most important prognostic indicators ranged from
six trials for age and functional status to 10 trials for gender. Nine
trials had similar groups at baseline for the key outcome measures
(see Table 5, Section 2). One trial (Corner et al, 1996) reported that
groups were not similar at baseline, that is, patients in the
intervention group had higher distress caused by breathlessness,
higher anxiety levels and greater difficulty performing activities of
daily living.
All 13 trials gave a relatively detailed description of the
intervention. With regard to care in the control group, nine trials
explicitly mentioned patients received usual, standard or routine
care. Five of these trials (Bredin et al, 1999; Goodwin et al, 2001;
Sloman, 2002) gave a fairly detailed description of this type of care.
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Outcome
a
Measures (instruments)
b
Statistically significant
Study Participants
Interventions
I¼intervention and C¼ control Po0.05
Change
score
c
Connor (1992) California, USA
Study quality:
Concealed treatment allocation: unclear
Cointerventions: unclear
Compliance: unclear
Dropouts: 57%, n and reasons overall described, unclear
if comparable between groups
Intention to treat: no, patients lost clearly not in analysis
Terminally ambulatory ill cancer patients
Excluded if: Karnofsky o50 or
cognitively impaired
Disease stage: stage IV 100%
Gender: 79% female
Mean age (range): 61 year (35–80
year)
I-group: counselling (n¼13)
Content: interview with patient, including
questions about, for example, the most difficult
aspects of having cancer? patients’ believes
about recovering from this illness and death?
Duration: once
Setting: inpatient
Format: individual, structured, therapist-
delivered,
d tailor-made
C-group: usual care (no intervention) (n¼11)
Emotional functioning:
Death anxiety (DAS)
Denial (DMI)
NS
+
—
Small
Arathuzik (1994) Massachusetts, USA
Study quality:
Concealed treatment allocation: unclear
Cointerventions: unclear
Compliance: strict written protocol was followed to
administer the intervention
Compliance monitored: unclear
Dropouts: unclear
Intention to treat: unclear
Patients with confirmed metastatic
breast cancer and experiencing physical
pain
Excluded if: brain metastasis or terminal
stage
Disease stage: stage IV 100%
Gender: 100% female
Age range: 31–80 years (46%460
years)
I-group 1: behaviour therapy – relaxation and
visualisation (n¼8)
Content: discussion of a detailed description of;
effects of relaxation on body and visualisation or
mental images on the mind; specific breathing
exercise, progressive muscle relaxation exercise
and visualisation that would be practiced;
conditions required to practise these exercises.
Deep breathing exercise, relaxing muscle
groups and visualisation exercises.
Duration: once 75min
Setting: in-/outpatient
Format: individual, structured, nurse-delivered,
standardised
I-group 2: behaviour therapy - relaxation,
visualisation and cognitive coping skills training
(n¼8); setting and format idem as I-group 1
Content: as I-group 1 adding to the discussion: a
detailed description of the effects of distraction
on pain and a review of written handouts on 23
methods of distraction.
Instruction in specific positive affirmation such as
‘I can manage my pain...’
Directed in practicing these affirmations and
refocusing negative thoughts and feelings.
Duration: once 120min
C-group: usual care (routine care and pain
medication on an as needed basis) (n¼8)
Emotional functioning:
I-group 1: POMS subscales
I-group 1: ability to decrease
pain (Rosenstiel)
I-group 2: POMS subscales
I-group 2: ability to decrease
pain (Rosenstiel)
Physical functioning:
I-group 1 and I-group 2: pain
distress (Johnson Pain Distress
scale)
NS
+
NS
+
NS
—
Large
—
Moderate
—
Corner et al (1996) London, UK
Study quality:
Concealed treatment allocation: unclear
Cointerventions: unclear
Compliance: unclear
Dropouts: 41%, n and reasons described by group,
comparable between groups
Intention to treat: no, patients lost clearly not in analysis
Patients with non-small cell lung cancer
who completed chemotherapy or
radiotherapy suffering breathlessness
Excluded if: not mentioned
Disease stage: stage IV 100%
Gender: 40% female
Median age:
Intervention group¼55 years
Control group¼69 years
I-group: counselling and behaviour therapy
(n¼19)
Content:
Detailed assessment of patient’s breathlessness,
their disease and feelings about the future.
Advice and support were given on methods of
managing breathlessness and involving family
members.
Breathing retraining exercises.
Goal setting to assist patient to learn breathing
Emotional functioning:
Anxiety (HADS)
Depression (HADS)
Physical functioning:
Distress due to breathlessness
(VAS)
Ability to walk distances/climb
stairs (Functional Capacity
Scale)
NS
NS
+
+
—
—
Large
Small
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land relaxation techniques.
Duration: weekly 1h, 3–6 weeks
Setting: outpatient
Format: individual, structured, nurse-delivered,
tailor-made
C-group: usual care (detailed assessment of
breathlessness - no training or counselling)
(n¼15)
Difficulties performing ADL
(checklist)
+ Small
Bredin et al (1999) London, UK
Study quality:
Concealed treatment allocation: yes
Cointerventions: pharmacological interventions
monitored and checked for balance
Compliance: supervision, audits, using practice guideline
to deliver the intervention
Compliance monitored: yes, by completing checklist
Dropouts: 41%, n and reasons described by group, not
comparable between groups
Intention to treat: yes
Patients with (non-) small cell lung
cancer/mesothelioma who completed
treatment and reporting breathlessness
Excluded if: not mentioned
Disease stage: stage IV 100%
Gender:
Intervention group¼female 20%
Control group¼female 33%
Mean age (range):
Intervention group¼68 years (41–82
years)
Control group¼67 years (41–83
years)
I-group: counselling and behaviour therapy
(n¼52)
Content:
Detailed assessment of breathlessness and
factors that ameliorate or exacerbate it.
Advice and support for patients and their
families on ways of managing breathlessness.
Exploration of the meaning of breathlessness,
their disease, and feelings about the future.
Training in breathing control techniques,
progressive muscle relaxation, and distraction
exercises.
Goal setting to complement breathing and
relaxation techniques, to help in the
management of functional and social activities
and to support the development and adoption
of coping strategies.
Early recognition of problems warranting
pharmacological or medical intervention.
Duration: weekly, 3–8 weeks
Setting: outpatient, nursing clinic
Format: individual, structured, nurse-delivered
and tailor-made
C-group: usual care (standard care, all patients
had access to routinely available supportive
care, that is, pharmacological, palliative
treatments and treatment of associated
problems such as anxiety or depression)
(n¼51)
Emotional functioning:
Anxiety (HADS)
Depression (HADS)
Psychological symptom distress
(RSCL)
Physical functioning:
Physical symptom distress
(RSCL)
Activity level (RSCL)
Distress due to breathlessness
(VAS)
Global measure of QoL:
QoL (RSCL)
NS
+
NS
+
+
+
NS
—
Moderate
—
Large
Moderate
Large
—
Edelman et al (1999) Sydney, Australia
Study quality:
Concealed treatment allocation:yes
Cointerventions: participation in outside groups
monitored and tested
Compliance: unclear
Dropouts: 25%, n and reasons described overall,
comparable between groups
Intention to treat: no, patients lost clearly not in analyses
Patients with metastatic breast cancer
Excluded if: psychiatric or brain disorder;
drug/alcohol dependency
Disease stage: stage IV 100%
Gender: 100% female
Mean age (range): 50 years (29–65
years)
I-group: behaviour therapy (cognitive–
behavioural therapy techniques) and social
support (n¼62)
Content:
At the start of the programme a manual was
given.
Handouts and homework exercises were given
at every session.
Basic cognitive skills were taught, including how
to identify and challenge maladaptive thoughts
and beliefs.
Emotional functioning:
Anxiety (POMS)
Depression (POMS)
Anger (POMS)
Fatigue (POMS)
Confusion (POMS)
Vigour (POMS)
Total Mood Diaturbance
(POMS)
Self-esteem (Coopersmith
Self Esteem Inventory)
NS
+
NS
NS
NS
NS
+
+
—
Small
—
—
—
—
Small
Small
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example, deep relaxation/meditation as a tool
for managing anxiety. A relaxation tape was
given to practise on a regular basis.
Goal setting and problem solving to gain a
greater sense of control.
The first hour of each session was spent on
discussing homework exercises, involving, for
example, the recording of potentially stressful
situations that arose during the week, identifying
and disputing maladaptive thoughts and
underlying beliefs. Participants were also asked
to suggest ‘positive actions’ that they could take
in order to resolve potentially problematic
situations.
In the second half of each session a particular
theme was discussed. This was followed by
discussion with participants reflecting on ways in
which they could apply the discussed strategies
to their own particular circumstances and
experiences.
Duration: weekly, 8 weeks
Setting: outpatient
Format: group, structured, therapist-delivered
and tailor-made
C-group: usual care (standard oncological care)
(n¼62)
Scholten et al (2001) Austria
Study quality:
Concealed treatment allocation: unclear
Cointerventions: unclear
Compliance: unclear
Dropouts: unclear
Intention to treat: unclear
Patients with metastatic breast cancer
Excluded if: central nervous system
metastasis
Disease stage: stage IV 100%
Gender: 100% female
Mean age (s.d.):
Intervention group¼61.6 years (8.7
years)
Control group¼62.2 years (8.1 years)
I-group: behaviour therapy – cognitive and
behavioural approaches (n¼20)
Content:
Strategies as problem solving, regaining control,
setting new goals for the future.
Therapy focused on patients’ coping strategies,
self-esteem and femininity, overcoming feeling
helpless, negative thoughts and depression, and
promotion of a fighting spirit.
For symptom control, behavioural techniques
(exercises in self-hypnosis and progressive
muscle relaxation) were employed.
Duration: 6 months
Setting: outpatient
Format: individual, structured, therapist-
delivered and tailor-made
C-group: usual care (patients received no
psychosocial support during observation period)
(n¼23)
Emotional functioning:
Cognitive, emotional and
behavioural coping skills (semi-
structured interviews)
Global measures of QoL:
(Non-) health related quality of
life (VAS)
NS
NS
—
—
Classen et al (2001) California, USA
Study quality:
Patients with confirmed metastatic or
recurrent breast cancer
I-group: behaviour therapy (cognitive–
behavioural approaches) and social support
Emotional functioning:
Total Mood Disturbance + Small
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Cointerventions: all patients were offered self-directed
education intervention, use was monitored and checked
for balance.
Compliance: supervision, use of protocol to deliver
intervention
Compliance monitored: unclear
Dropouts: 18%, n and reasons described by group,
acceptable
Intention to treat: yes (for patients with at least one
follow-up measurement)
Excluded if: Karnofsky score o70 or no
metastasis beyond supraclavicular nodes
Disease stage: stage IV 100%
Gender: 100% female
Mean age (s.d.):
Intervention group¼54.0 years (10.7
years)
Control group¼52.9 years (10.7 years)
(n¼58)
Content: Supportive Expressive Therapy (SET).
Therapists were trained to facilitate discussion in
an emotionally expressive rather than a didactic
format of the following themes:
Fears of dying and death including dealing with
death of group members.
Reordering life priorities.
Improving support from and communication
with family and friends.
Integrating a changed self- and body image.
Improving communication with physicians.
Learning self-hypnosis for pain an anxiety
control.
Through sharing of their experiences, group
members became role models for one another.
Leaders kept members focused on issues
central to their diagnoses of metastatic breast
cancer and on facing and grieving for their losses
Duration: weekly 1.5h for 1 year
Setting: outpatient
Format: group, unstructured, therapist-delivered,
tailor-made
C-group: usual care (no specific description)
(n¼44)
(POMS)
Intrusion and avoidance – total
score (IES)
+ Small
Goodwin et al (2001) Canada
Study quality:
Concealed treatment allocation: yes
Cointerventions: all patients received educational
materials every 4–6 months. Unclear if use was
monitored. Participation in support groups was
monitored and proved comparable between groups.
Compliance: use of protocol, every 9–12 months
workshops, review of randomly selected videotaped
sessions.
Compliance monitored: unclear
Dropouts: 34%, n and reasons described overall,
comparable between groups
Intention to treat: yes
Patients with confirmed metastatic
breast cancer
Excluded if: life expectancy o3 months;
no metastasis beyond ipsilateral axilla;
central nervous system metastasis;
untreated major depression; planned
participation in therapist-led support
group for patients with metastatic
breast cancer outside the study center
Disease stage: stage IV 100%
Gender: 100% female
Mean age (s.d.):
Intervention group¼49.5 years (8.4
years)
Control group¼51.5 years (10.3 years)
I-group: behaviour therapy (cognitive–
behavioural approaches) and social support
(n¼158)
Content: SET – see Classen (2001)
Duration: 90min weekly, 1 year
Setting: outpatient
Format: group, unstructured, nurse- and
therapist-delivered, tailor-made
C-group: usual care (patients did not receive any
psychological therapy as part of the study but
could however participate in peer support
groups or therapist led support groups that did
not involve SET) (n¼77)
Emotional functioning:
Anxiety (POMS)
Depression (POMS)
Anger (POMS)
Fatigue (POMS)
Confusion (POMS)
Vigour (POMS)
Total Mood Disturbance
(POMS)
Physical functioning:
Experience of suffering
+
+
+
NS
+
NS
+
NS
Small
Small
Small
—
Small
—
Small
—
Giese-Davis et al (2002) California, USA
Study quality:
Concealed treatment allocation: yes
Cointerventions: all patients were offered educational
materials and 1-year membership of a health library.
Unclear if use was monitored.
Compliance: ongoing supervision, use of protocol
Patients with documented metastatic or
recurrent breast cancer
Excluded if: Karnofsky score o70 or no
metastasis beyond supraclavicular nodes
Disease stage: stage IV 100%
Gender: 100% female
I-group: behaviour therapy (cognitive–
behavioural approaches) and social support
(n¼64)
Content: SET – see Classen (2001)
Duration: weekly 1.5h for 1 year
Setting: outpatient
Format: group, unstructured, therapist delivered,
Emotional functioning:
Anger control (CECS)
Depression control (CECS)
Anxiety control (CECS)
Total score (CECS)
Restraint (WAI)
Defensiveness (WAI)
+
+
NS
+
+
NS
NE
e
NE
e
NE
e
Small
Small
—
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ClinicalCompliance monitored: unclear
Dropouts: 42%, n and reasons described overall, not
comparable between groups
Intention to treat: yes, for patients with at least one
follow-up measurement
Mean age (s.d.):
Intervention group¼52.7 years (10.5
years)
Control group¼53.8 years (10.5 years)
tailor-made
C-group: usual care (no specific description)
(n¼61)
Confidence communicating
emotions (SESES-C)
Confidence confronting death
(SESES-C)
Confidence focusing on present
moment (SESES-C)
Emotional self-efficacy total
score (SESES-C)
NS
NS
+
NS
—
—
NE
e
—
Sloman (2002) Israel
Study quality:
Concealed treatment allocation: unclear
Cointerventions: unclear
Compliance: unclear
Dropouts: unclear
Intention to treat: unclear
Ambulatory patients with advanced
cancer experiencing anxiety and
depression without ever been trained in
progressive muscle relaxation (PMR) or
guided imagery (GI) Excluded if: not
mentioned
Disease stage: stage IV 63%
Gender: 46% female
Mean age: 54.4 years (range 27–79
years)
I-group 1: behaviour therapy - progressive
muscle relaxation training (n¼14)
Content:
Nurse explained the nature of the session and
turned on the taped instructions. At the end the
nurse had a brief discussion concerning any
problems that patients may have experienced in
following the instructions.
The tape recorder was left to practice PMR
technique twice daily.
Making of follow-up appointments for the nurse
to visit subjects twice weekly to repeat the
sessions and deal with any related problems.
Cassette tapes contained clear instructions by a
clinical psychologist that guided the subjects in
the use of the techniques.
Duration: 30min, twice weekly, 3 weeks
Emotional functioning:
I-group 1:
Anxiety (HADS)
Depression (HADS)
I-group 2:
Anxiety (HADS)
Depression (HADS)
I-group 3:
Anxiety (HADS)
Depression (HADS)
Global measures of QoL:
I-group 1: Functional Living
Index Cancer Scale (FLIC)
I-group 2: Functional Living
Index Cancer Scale (FLIC)
I-group 3: Functional Living
Index Cancer Scale (FLIC)
NS
+
NS
+
NS
+
+
+
+
—
Small
—
Small
—
Small
Small
Small
Small
Setting: home care
Format: individual, structured, nurse delivered,
standardized
I-group 2: behaviour therapy-guided imagery;
content, duration, setting and format idem as I-
group 1 but focus on GI (n¼14)
I-group 3: behaviour therapy PMR+GI;
content, duration, setting and format idem as I-
group 1, but focus on PMR training+GI (n¼14)
C-group: usual care (no relaxation or imagery
training; to control for placebo effect a nurse
spent an equal amount of contact time with
control subjects and had a general discussion
about their concerns relating to their health,
nursing care, and medical treatments) (n¼14)
QoL¼quality of life; s.d.¼standard deviation; NS¼nonsignificant.
aOutcomes outside the scope of this review are not presented.
bPOMS¼Profile of Moods Scale; HADS¼Hospital Anxiety and Depression Scale;
RSCL¼Rotterdam Symptom Checklist; IES¼Impact of Event Scale; DAS¼Death Anxiety Scale; DMI¼ Defense Mechanisms Inventory; CECS¼Courtauld Emotional Control Scale; WAI¼Weinburger Adjustment Inventory;
SESES-C¼ Stanford Emotional Self-Efficacy Scale - Cancer; FLIC¼ Functional Living Index-Cancer Scale.
cMagnitude of the difference in change scores between groups relative to the scale used – small¼change score o25%;
moderate¼change score between 25 and 50%; large¼change score 450%.
dWhen therapist is written psychotherapist and psychologist are meant.
eNE¼not evaluable, in this trial slopes analysis was used to measure change over
time and only mean change of slope was given for this measure.
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lAvoidance of cointerventions by trial design or monitoring of
the use of cointerventions was mentioned in five trials. Concerning
avoidance of cointerventions by trial design, three trials (Classen
et al, 2001; Goodwin et al, 2001; Giese-Davis et al, 2002) controlled
for imbalance in the use of information by offering educational
materials to patients in both the intervention and control group. Of
which, the trial of Classen et al (2001) also mentioned the
monitoring of the use of these educational materials. Participation
of patients in outside support groups was monitored by Edelman
et al (1999) and Goodwin et al (2001). Bredin et al (1999)
monitored the use of pharmacological interventions.
One trial (Bredin et al, 1999) explicitly mentioned the
monitoring of compliance. Six trials (Arathuzik, 1994; Bredin
et al, 1999; Classen et al, 2001; Goodwin et al, 2001; Giese-Davis
et al, 2002) mentioned the use of a protocol, supervision, reviews
of videotaped intervention sessions or side visits to ensure that the
intervention was delivered as intended.
The withdrawal/dropout of patients was described in seven
trials; three trials (Corner et al, 1996; Bredin et al, 1999; Classen
et al, 2001) described number and reasons for dropout by group
and four trials (Connor, 1992; Edelman et al, 1999; Goodwin et al,
2001; Giese-Davis et al, 2002) described this for the total sample.
The drop-out rate was considered acceptable when 20% or less
(Classen et al, 2001) or comparable between groups (Corner et al,
1996; Edelman et al, 1999; Goodwin et al, 2001). The dropout rate
ranged from 18 to 57%.
Approximately one-third of the trials (Bredin et al, 1999; Classen
et al, 2001; Goodwin et al, 2001; Giese-Davis et al, 2002) explicitly
stated that intention-to-treat analyses were used to deal with
patients who were lost to follow-up. However, two trials (Classen
et al, 2001; Giese-Davis et al, 2002) limited this intention-to-treat
analyses to patients with at least one follow-up measurement.
Three trials (Connor, 1992; Corner et al, 1996; Edelman et al, 1999)
did not use intention-to-treat analyses, that is, patients lost to
follow-up were clearly not in the analyses.
Parametrical statistical tests were used in 10 trials (Connor,
1992; Arathuzik, 1994; Edelman et al, 1999; Classen et al, 2001;
Goodwin et al, 2001; Giese-Davis et al, 2002; Sloman, 2002).
Nonparametrical tests were used in three trials (Corner et al, 1996;
Bredin et al, 1999; Scholten et al, 2001). Eight trials compared four
or more outcome measures. All trials used a P-value of 0.05 as the
limit of statistical significance.
Effects on QoL
Outcomes of trials that aimed at improving one of the dimensions
of patients’ QoL are summarised in Table 4.
Emotional functioning – distress Anxiety and depression
as measures of emotional functioning were used in 10 trials
(Arathuzik, 1994; Corner et al, 1996; Bredin et al, 1999;
Edelman et al, 1999; Classen et al, 2001; Goodwin et al, 2001;
Sloman, 2002). One trial (Goodwin et al, 2001) showed a
statistically significant treatment effect for anxiety. Whereas in
six trials (Sloman et al, 2002; Bredin et al, 1999; Edelman et al,
1999; Goodwin et al, 2001), a statistically significant treatment
effect for depression was found. Patients’ self-esteem improved
significantly following the combined intervention of behaviour
therapy and group support (Edelman et al, 1999). No significant
effect was found for death anxiety as an outcome of an individual
counselling intervention in a sample of ambulatory terminally ill
patients (Connor, 1992).
Emotional functioning – coping In five of the six trials (Connor,
1992; Arathuzik, 1994; Classen et al, 2001; Scholten et al, 2001;
Giese-Davis et al, 2002) in which patients’ coping abilities were
measured, a significant treatment effect was found. One of these
trials (Giese-Davis et al, 2002) investigated the effects of
supportive-expressive group therapy on emotion-regulation out-
come measures and found a significant reduction in suppression of
feelings of anger, sadness and fear while also showing a significant
improvement in greater restraint of aggressive, inconsiderate,
irresponsible and impulsive behaviour. Furthermore, patients in
the treatment group reported that they were significantly better
able to focus on the present. Another trial (Classen et al, 2001) also
investigating supportive-expressive group therapy showed a
significant reduction in total scores on IES, measuring symptoms
of intrusion and avoidance. Two trials (Arathuzik, 1994) examin-
ing individual behavioural therapy showed a significant improve-
ment of patients’ perceived ability to decrease/control their pain.
One trial (Connor, 1992) found a significant reduction in the use of
denial by patients receiving individual counselling compared to
patients in the control group.
Physical functioning Positive effects were seen in two of
five trials (Arathuzik, 1994; Corner et al, 1996; Bredin et al,
1999; Goodwin et al, 2001) measuring physical functioning.
Both trials (Corner et al, 1996; Bredin et al, 1999) investigated
the effects of a nursing intervention for breathlessness in
patients with lung cancer involving a combination of individual
behaviour therapy and counselling, and found a significant
improvement for physical symptom distress, activity level and
functional capacity.
Global measures of QoL Significant improvements of QoL were
found in three of the five trials (Bredin et al, 1999; Scholten et al,
2001; Sloman, 2002) measuring overall QoL. More specifically,
results showed an improvement of scores on the Functional Living
Index – cancer scale (Sloman, 2002).
Table 5 Methodological quality of included trials (n¼13)
No. of trials (%)
Quality indicator
Yes,
fulfilled No Unclear
Method of randomisation 13 (100%) — —
Adequate concealment of allocation 5 (38%) — 8 (62%)
Groups similar at baseline:
Gender 10 (77%) — 3 (23%)
Age 6 (46%) 3 (23%) 4 (31%)
Functional status 6 (46%) 1 (8%) 6 (46%)
Emotional distress 8 (62%) 1 (8%) 4 (31%)
Key outcome measures 9 (69%) 1 (8%) 3 (23%)
Cointerventions:
Cointerventions avoided by trial design 3 (23%) 10 (77%) —
Cointerventions monitored 4 (31%) — 9 (69%)
Compliance monitored and acceptable 6 (46%) — 7 (54%)
Blinded outcome assessment for at least one
key outcome
— 13 (100%) —
Relevant outcome measures 13 (100%) — —
Withdrawal/dropout rate:
N and reasons described 7 (54%) — 6 (46%)
% lost p20% or comparable between groups 4 (31%) 2 (15%) 7 (54%)
Comparable timing of outcome assessment in
both groups
13 (100%) — —
Intention-to-treat analyses explicitly stated 4 (31%) 3 (23%) 6 (46%)
Psychosocial interventions for patients with advanced cancer
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lDISCUSSION
Main results
Evidence to date indicated that psychosocial interventions
pertaining to the field of behaviour therapy were beneficial
for patients with advanced cancer. Of 13 included trials, 12
showed positive effects on one or more indicators of QoL. The
main benefit is an improvement of depression and feelings of
sadness.
Coping also improved, especially a reduction in suppression of
negative affect and an improvement in the restraint of incon-
siderate and impulsive behaviour. As most effects were of a small
magnitude, it is unclear if these effects are of clinical significance.
Yet, as the effects reflected changes on measures that are important
to patients with advanced cancer, that is, alleviating distress or
improving patient’s (perceived) functioning in daily life, even
small effects can be clinically significant.
This review illustrated that the most frequently used type of
psychosocial interventions for patients with advanced cancer was
behaviour therapy as a single or combined intervention. Behaviour
therapy was associated with cognitive-behavioural techniques and
is an approach used to modify behaviour. This approach is based
on the belief that cognitions prompt and mediate behaviour and
that they are amenable to change. Behaviour therapy intends to
help patients acquire strategies to better manage their behaviour,
for example, increasing such skills as voluntary relaxation of the
skeletal muscles, diverting attention away from pain or other
distressing symptoms, reinterpreting pain or other distressing
symptoms by changing unhelpful thoughts and believes, and
developing a view of oneself that emphasises a sense of mastery of
control and self-reinforcement of adaptive behaviour.
The review showed that therapists, that is, psychotherapist or
psychologists, nurses or nurses and therapists combined, delivered
behaviour therapy. It is worth noting that the interventions given
by a therapist were tailor-made, predominantly with a group
format and taking longer than 8 weeks, whereas interventions
delivered by nurses or nurses and therapists combined were
predominantly standardised, individual and given over an 8-week
period or shorter. This review, however, does not answer the
question whether certain characteristics of the intervention, for
example, shorter or longer duration, an individual or group format,
standardised or tailor-made and delivered by either therapists,
nurses or nurse and therapist combined, might influence the effect,
as it was not possible to perform a meta-analysis and subgroup
analyses because of the heterogeneity of the data.
Furthermore, the results of the individual trials illustrate that
outcome measures pertaining to the QoL dimension of emotional
functioning, that is, anxiety and depression, were most frequently
measured. Physical functioning and global measures of QoL were
less frequently used. Similarly, measures of social functioning were
not used. In addition, variables concerning the spiritual or
existential domain of QoL were never measured. Especially in
the case of patients with advanced cancer, it appeared that this
domain is of great importance to patients and should not be
ignored (Cohen et al, 1996; Rinck et al, 1997; Skeel, 1998).
Limitations
This review was conducted rigorously and provides a balanced
assessment of the current evidence. The search was extensive and
it is unlikely that controlled trials were missed. Efforts have been
made to identify unpublished studies. Despite this the review may
be subject to publication bias, although we did not find that trials
reporting beneficial results were the methodological weaker trials.
A formal method of assessing publication bias, for example, funnel
plots, could, however, not be performed because of great
heterogeneity among the trials.
The conclusions that can be drawn from this review should be
treated with some caution, because of the limitations in the
evidence. There were problems with the validity of the studies.
Limited details of the methods used in the trial, including methods
of randomisation, monitoring of the use of cointerventions and
compliance, were available. Especially in trials with advanced
cancer patients, where care needs and preferences of patients vary
greatly and where because of this cointerventions cannot be
avoided, it is of great importance that all cointerventions are
monitored and checked for imbalance between groups (Rinck et al,
1997). The same holds true for the monitoring of compliance.
Although blinding of the outcome assessment is undoubtedly an
important methodological quality indicator, in trials where out-
come measures are self-reported and patients know which group
they were allocated to, this is clearly impossible. Another limitation
concerns the attrition of patients. In trials with advanced cancer,
patients’ untimely attrition must be expected and accounted for;
however, limited details concerning patient attrition were available
in about half of the included trials. A further limitation concerns
the similarity of groups at baseline for key outcome measures. One
trial reported an imbalance in baseline values and possibly affected
the outcomes of physical functioning in this particular trial.
Another limitation involves the statistical power of the trials. Some
trials were clearly underpowered. On the other hand, it appeared
that even these underpowered trials showed statistical significant
changes, which possibly could have achieved the level of clear
clinical significance when adequately powered. Also, limited details
concerning the appropriateness of statistical analyses were given.
Another limitation concerns the multiple comparisons that were
made in most of the trials without adjusting their limit of statistical
significance. However, to elude this ‘data-dredging’ phenomenon
that possibly occurred in some of the trials, relevant outcome
measures for this review were a priori selected.
The generalisability of the results from the included trials is
questionable to the extent that performance status and life expectancy
criteria applied in the majority of the studies will have led to the
selection of patients who may have been somewhat healthier than
those who would be offered psychosocial intervention in practice.
CONCLUSION
In summary, there is an indication that psychosocial intervention
using cognitive-behavioural techniques are beneficial for the QoL of
patients with advanced cancer, especially in the domain of
emotional functioning. However, evidence is limited as there have
been few large methodological strong trials. On the other hand, it is
nearly impossible that all methodological quality criteria will be
met when conducting a trial in the field of palliative care.
Undoubtedly, scientific rigour should always be aimed at. However,
at the same time one needs to consider that given the circumstances
of providing care to patients with advanced cancer, this demand
resembles a mathematical asymptotic function, where regardless of
effort total rigour cannot be achieved. As nearly all included trials
focused on behaviour therapy, nothing can be inferred about the
effectiveness of nonbehaviour therapy techniques.
Based on the results and above consideration, the authors of this
review conclude that practitioners and health educators should
consider an intervention involving techniques of behaviour
therapy to address emotional distress in patients with advanced
cancer. It remains unclear if a particular format of behaviour
therapy is more beneficial than others. More research testing the
effects of psychosocial interventions in patients with advanced
cancer is needed. For future research, it is recommended to (also)
involve outcome measures pertaining to the existential/spiritual
domain of QoL, to address the issues of clinical significance and
statistical power, to provide information in sufficient detail making
methodological assessment possible, to form comparable groups
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lon key outcome measures and to monitor the use of cointerven-
tions and compliance.
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